Loading clinical trials...
Loading clinical trials...
Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men
The purpose of this research study is to understand the effects of testosterone and estrogen on the body's response to the hormone insulin.
The investigators will examine the effects of testosterone on insulin sensitivity and body composition in men. This study may lend greater insight into the increased risk of diabetes evident in men with low circulating levels of testosterone. Three drugs will be used in this study: acyline, given by injection; testosterone (T) gel that is applied to the skin; and letrozole, which is an oral drug that blocks the conversion of androgens (male hormones) to estrogens (female hormones). Acyline inhibits the production of luteinizing hormone (LH) and follicle stimulating hormone (FSH). When acyline stops the production of these hormones, it blocks the signal from the brain that stimulates the testicles to make testosterone. Adding testosterone to acyline will restore physiologic levels of testosterone in some study participants. One group of men will receive T gel with letrozole, an aromatase inhibitor; these men will have normal levels of testosterone but low levels of estrogen in the blood. This design will enable determination of the respective metabolic effects of testosterone and estrogen.
Age
25 - 55 years
Sex
MALE
Healthy Volunteers
Yes
University of Washington
Seattle, Washington, United States
Start Date
June 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
December 1, 2017
Last Updated
May 8, 2018
53
ACTUAL participants
Acyline
DRUG
Testosterone 1.62% gel
DRUG
Letrozole
DRUG
Placebo gel (for Testosterone 1.62% gel)
DRUG
Placebo pill (for Letrozole)
DRUG
Lead Sponsor
University of Washington
NCT07472881
NCT01143454
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions